Literature DB >> 22855684

White matter abnormalities in patients with focal cortical dysplasia revealed by diffusion tensor imaging analysis in a voxelwise approach.

Viviane de Carvalho Fonseca1, Clarissa Lin Yasuda, Guilherme Garlipp Tedeschi, Luiz Eduardo Betting, Fernando Cendes.   

Abstract

BACKGROUND: Diffusion tensor imaging (DTI) allows the analysis of changes in microstructure, through the quantification of the spread and direction of water molecules in tissues. We used fractional anisotropy (FA) maps to compare the integrity of WM between patients and controls. The objective of the present study was to investigate WM abnormalities in patients with frontal lobe epilepsy secondary to focal cortical dysplasia (FCD).
MATERIALS AND METHODS: We included 31 controls (12 women, 33.1 ± 9.6 years, mean ± SD) and 22 patients (11 women, 30.4 ± 10.0 years), recruited from our outpatient clinic. They had clinical and EEG diagnosis of frontal lobe epilepsy, secondary to FCD detected on MRI. Patients and controls underwent 3T MRI, including the DTI sequence, obtained in 32 directions and b value of 1000 s/mm(2). To process the DTI we used the following softwares: MRIcroN and FSL/TBSS (tract-based spatial statistics). We used a threshold-free cluster enhancement with significance at p < 0.05, fully corrected for multiple comparisons across space.
RESULTS: Areas with FA reduction in patients were identified in both hemispheres, mainly in the frontal lobes, cingulum, and forceps minor (p = 0.014), caudate e anterior thalamic radiation (p = 0.034), superior longitudinal fasciculus (p = 0.044), uncinate fasciculus, and inferior fronto-occipital fasciculus (p = 0.042).
CONCLUSION: Our results showed a widespread pattern of WM microstructural abnormalities extending beyond the main lesion seen on MRI (frontal lobe), which may be related to frequent seizures or to the extent of MRI-invisible portion of FCD.

Entities:  

Keywords:  DTI; FA; FCD; WM; extratemporal focal epilepsy; tract-based spatial statistic

Year:  2012        PMID: 22855684      PMCID: PMC3405461          DOI: 10.3389/fneur.2012.00121

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


Introduction

Epilepsy secondary to focal cortical dysplasia (FCD) usually begins early in life, is often refractory to antiepileptic drug (AED) therapy, and a frequent cause of focal motor status or focal epilepsy, which may be life-threatening (Desbiens et al., 1993). The term FCD designates a spectrum of abnormalities of the laminar structure of the cortex (Guerrini and Parrini, 2010; Blümcke et al., 2011) and is present in a significant proportion of epilepsy surgical series, in particular in the pediatric population (Fauser et al., 2006; Blümcke et al., 2011). Barkovich et al. (2001) classified different types of FCD as malformations due to abnormal neuronal proliferation or due to abnormal cortical organization, that may be located in areas of eloquent cortex. In addition, the epileptogenic zone may be more extensive than the lesion visualized on MRI alone (Palmini et al., 1995; Rosenow et al., 1998). Intracranial EEG recordings have demonstrated that epileptic activity exhibits complex propagation patterns within and between hemispheres (Duchowny et al., 2000), often extending beyond the MRI visible lesion (Tassi et al., 2002; Najm et al., 2007). Diffusion tensor imaging (DTI) is a non-invasive imaging technique that can examine molecular diffusion of water within the brain by applying gradients in at least six non-collinear directions. DTI can evaluate white matter integrity and may detect abnormalities in earlier stages than conventional T2- or T1-weighted imaging (Pierpaoli et al., 1996; Lee et al., 2004). The measurement of white matter integrity used in this study is fractional anisotropy (FA), which is determined by the directional magnitude of water diffusion in three-dimensional space. The tract-based spatial statistic (TBSS) provides an automated whole brain voxel-by-voxel analysis of FA without a priori bias for different brain regions. The aim of this study was to investigate white matter changes in patients with frontal lobe epilepsy due to FCD using DTI.

Materials and Methods

We studied 31 controls (12 women, 33.1 ± 9.6 years, mean ± SD) and 22 patients (11 women, 30.4 ± 10.0 years) with MRI defined FCD, recruited from our outpatient clinic at our University Hospital from May 2009 to April 2010. Informed consent was obtained for participation in the studies, approved by the Internal Review Board of our institution. Patients started seizures at mean age of 8.5 years and presented an average of 12.6 seizures per month. They had clinical and EEG diagnosis of frontal lobe epilepsy, probably secondary to FCD (Table 1). Patients and controls underwent 3T MRI, including the DTI sequence. A standardized protocol was performed on a 3 Tesla Achieva-Intera Philips®, release 2.6.1.0. The DTI acquisition was performed in axial plane obtained in 32 directions; 2 mm thickness, with echo time 60, factor-b 1000, reconstructed matrix 128 × 127, field of view (FOV), 232 × 232. In addition, all patients had a 3T MRI epilepsy protocol that included 3 mm coronal T1-weighted inversion recovery, 3 mm coronal T2-weighted multi-echo sequence, 3 mm coronal and axial FLAIR, volumetric T1-weighted sequence with 1 mm isotropic voxels, and volumetric T2-weighted sequence with 1 mm × 1 mm × 1.5 mm voxels. All images were analyzed in a workstation with high resolution widescreen monitor. Multiplanar reconstructions on T1 and T2 volumetric sequences were performed for all patients. The neuroimaging characteristics for diagnosing probable FCD were based on a recent proposal for classification by Blümcke et al. (2011) and included increased cortical thickness, blurring of the cortical-white matter junction, increased signal on T2-weighted images, a radially oriented linear or conical transmantle stripe of T2 hyperintensity, cortical thinning, and localized brain atrophy (Blümcke et al., 2011).
Table 1

Summary of clinical presentation of patients with focal epilepsy secondary to MRI defined focal cortical dysplasia.

PatientAge (years)SexAge Sz. onsetSz. Freq.Family hist. Sz.Sz. typeAEDsFCD in MRIEEG
127F136YSPS-CPS-SGTCTPM. LGT. CBZR frontalL > R generalized ED
228F94NSPS-CPSCBZ. TPM. CLBL frontalL frontal ED
317F24YSPS-CPSCBZ. VPA. TPM. CLBL frontalL temporal ED
428F108NSPS-CPSCBZ CLBR parietal frontalBilateral L > R ED
527M230NSPS-CPS-SGTCDPK. LGTR frontalBilateral synchrony ED
626F64NSPS-CPSTPM. CBZ. C LBR frontalBi-frontal ED
718F86NSPS-CPSLGT. TPM. CLBR frontalR frontal ED
817M0.660YCPS-SGTSTPM. DPK. CLBR frontalR frontal ED
939M251NCPS-SGTSCBZL frontalL frontal ED
1032F74NSPS-CPS-SGTCCBZ. TPM. CLBL frontalL frontal ED
1136F21NCPS-SGTSLGT. CLZR frontalR frontal ED
1249F131NCPS-SGTSOXCL frontalBi-frontal ED
1333M44YCPS-SGTSLGT. VPA. CLZR frontalR frontal ED
1429M50.5NSPS-CPS-SGTCCBZR frontalR > L generalized ED
1526M172NSPS-CPSCBZ. CTG. CLB.R temporo-frontalBi-temporal ED
1623F912YSPS-CPS-SGTCLGT. CLBL frontalL frontal ED
1759F1820NSPS-CPSCBZL frontalL frontal ED
1830M130.5YCPS-SGTSCBZ. LGT. CLBL frontalL > R generalized ED
1918M0.830YSPS-CPSPB. DPKR frontalBi-frontal ED
2034M73YCPS-SGTSCBZ. TPML frontalL frontal ED
2137M616NSPS-CPSCBZ. VPAR temporo-frontalR frontal ED
2236M960YSPS-CPS-SGTCCBZ. CLB. TPML frontalL frontal ED

Age Sz. onset, age at seizure onset in years; family hist. Sz., presence (Y) or absence (N) of family history of seizures; Sz. type, type of seizures; SPS, simple partial seizures; CPS, complex partial seizures; SGTC, secondary generalized tonic-clonic seizures; AEDs, antiepileptic drugs; TPM, topiramate; LGT, lamotrigine; CBZ, carbamazepine; CLZ, clonazepam; DPK, divalproate; VPA, valproic acid; CLB, clobazan; OXC, oxacarbazepine; PB, phenobarbital; FCD in MRI, localization of focal cortical dysplasia on magnetic resonance imaging; EEG, electroencephalography; R, right; L, left; ED, epileptiform discharges.

Summary of clinical presentation of patients with focal epilepsy secondary to MRI defined focal cortical dysplasia. Age Sz. onset, age at seizure onset in years; family hist. Sz., presence (Y) or absence (N) of family history of seizures; Sz. type, type of seizures; SPS, simple partial seizures; CPS, complex partial seizures; SGTC, secondary generalized tonic-clonic seizures; AEDs, antiepileptic drugs; TPM, topiramate; LGT, lamotrigine; CBZ, carbamazepine; CLZ, clonazepam; DPK, divalproate; VPA, valproic acid; CLB, clobazan; OXC, oxacarbazepine; PB, phenobarbital; FCD in MRI, localization of focal cortical dysplasia on magnetic resonance imaging; EEG, electroencephalography; R, right; L, left; ED, epileptiform discharges. All patients were under investigation for epilepsy surgery and Table 1 shows the summary of their investigation. At this point only four of these patients have confirmation of FCD by pathology. For processing the DTI, all imaging data were transferred to a cluster of Linux workstations. The structural images were visually inspected for any structural abnormalities by a neuroimaging expert. First DICOM images were converted to 4D-Nifti file using the MRIcroN program. Preprocessing and analyses of diffusion data was done with an in-house protocol using FSL. For voxelwise analysis of FA values we applied TBSS (also included in FSL), with threshold-free cluster enhancement with significance at p < 0.05, fully corrected for multiple comparisons across space (Smith et al., 2006). For localizing the significant results we used the atlases offered by FSL (http://www.fmrib.ox.ac.uk/fsl/data/atlas-descriptions.html#wm). Of all patients included in the study, 12 had right-sided lesions and 10 had left-sided MRI lesions (male n = 11; female n = 11). The patients composed three groups for analysis. First the control group was compared with patients group who had right-sided FCD. The second analysis compared the control group with those patients that had left-sided FCD. Next, we analyzed all patients after flipping the images with right-sided lesions to the left side, versus controls. Comparison of FA values in patients with right-sided lesions versus normal controls. We identified a reduction of FA in these patients mainly in: forceps minor (p = 0.032), ipsilateral hemisphere, forceps minor (p = 0.042), and cingulum (p = 0.048) in the contralateral hemisphere (Figure 1A; Table A1 in Appendix).
Figure 1

(A) FA decrease in patient group with right-sided FCD. (B) FA decrease in patient group with left-sided FCD. (C) FA decrease in the analysis of patients with left and right-sided lesions altogether after flipping the MRIs with right-sided FCD lesions. The yellow/red voxel indicated brain regions where the FA was significantly reduced in patients with focal epilepsy when compared to controls.

Table A1

Areas of significant reduction of FA values for the comparison of patients with right-sided focal cortical dysplasia lesions versus normal controls.

Fractional anisotropy decrease – FCD right-sided
JHUMNIX, Y, Zp-Value
3%R forceps minor8%Frontal lobe83, 145, 910.032
3%L forceps minor6%Frontal lobe93, 143, 910.042
5%Forceps minor1%Frontal lobe99, 148, 910.048
8%Cimgulum1%Frontal lobe99, 148, 910.048

JHU, Areas according to the JHU white matter atlas; MNI, Areas according to the MNI coordinates.

Comparison of FA values in patients with left-sided lesions versus normal controls. Tract-based spatial statistic analysis showed extensive reduction of FA in areas involving both hemispheres; right anterior thalamic radiation and forceps minor (p = 0.022), left corticospinal tract and right corticospinal (p = 0.022), right inferior fronto-occipital fasciculus (p = 0.022), left cingulum e forceps minor (p = 0.014), anterior thalamic radiation, fasciculus uncinatus, left inferior fronto-occipital fasciculus (p = 0.036), left superior and inferior longitudinal fasciculus, and forceps major (p = 0.034; Figure 1B; Table A2 in Appendix).
Table A2

Areas of significant reduction of FA values for the comparison of patients with left-sided lesions versus normal controls.

Fractional anisotropy decrease – FCD left-sided
JHUMNIX, Y, Zp-Value
3%Forceps minor3%Frontal lobe91, 143, 910.014
16%Anterior thalamic radiation5%Frontal lobe69, 169, 910.022
3%R fronto-occiptal fasciculus5%Frontal lobe69, 169, 910.022
8%R anterior thalamic radiation1%Frontal lobe57, 158, 910.022
45%R anterior thalamic radiation20%Caudate68, 138, 910.036
3%R corticospinal tractUnidentified65, 122, 910.022
3%L corticospinal tractUnidentified65, 122, 910.022
3%Inferior R fronto-occiptal fasciculusUnidentified63, 97, 910.022
16%L cingulum1%Frontal lobe106, 160, 910.014
3%L fasciculus uncinatus1%Frontal lobe111, 168, 910.036
3%Inferior L fronto-occiptal fasciculus1%Frontal lobe111, 168, 910.036
45%L anterior thalamic radiation13%Caudate111, 136, 910.014
18%L superior longitudinal fasciculus (temporal part)1%Parietal lobe130, 80, 910.014
3%L superior longitudinal fasciculus2%Occipital lobe119, 65, 910.034
11%Inferior L fronto-occipital fasciculus1%Occipital lobe120, 65, 910.034
5%L inferior longitudinal fasciculus1%Occipital lobe120, 65, 910.034
5%L forceps major2%Occipital lobe119, 65, 910.034
8%Inferior L fronto-occipital fasciculus2%Occipital lobe119, 65, 910.034
18%L superior longitudinal fasciculus1%Parietal lobe130, 80, 910.034

JHU, Areas according to the JHU white matter atlas; MNI, Areas according to the MNI coordinates.

Comparison of FA values in all patients after flipping the images with right-sided lesions to the left side versus normal controls. (A) FA decrease in patient group with right-sided FCD. (B) FA decrease in patient group with left-sided FCD. (C) FA decrease in the analysis of patients with left and right-sided lesions altogether after flipping the MRIs with right-sided FCD lesions. The yellow/red voxel indicated brain regions where the FA was significantly reduced in patients with focal epilepsy when compared to controls.

Results

In this analysis the MRIs of patients with right-sided lesions were flipped, so all the lesions would be on the same side. We identified areas with reduced FA in the left superior longitudinal fasciculus (p = 0.022), left inferior longitudinal fasciculus (p = 0.032), inferior fronto-occipital fasciculus (p = 0.038), right and left anterior thalamic radiation (p = 0.042 and 0.022, respectively), left corticospinal tract (p = 0.042), cingulum and left forceps major (p = 0.048), left inferior fronto-occipital fasciculus (p = 0.032; Figure 1C; Table A3 in Appendix).
Table A3

Areas of significant reduction of FA values for the comparison of all patients after flipping the images with right-sided lesions to the left side versus normal controls.

Fractional anisotropy decrease – patients group flipping the images with right-sided lesions
JHUMNIX, Y, Zp-Value
3%Inferior R fronto-occipital fasciculus17%Frontal lobe60, 165, 910.038
3%R superior longitudinal fasciculus9%Frontal lobe59, 164, 910.044
3%R anterior thalamic radiation18%Frontal lobe62, 165, 910.068
3%L corticospinal tract1%Caudate67, 122, 910.042
8%R anterior thalamic radiation13%Caudate69, 122, 910.042
3%R corticospinal tractUnidentified64, 119, 910.046
3%Forceps minor8%Frontal lobe95, 144, 910.014
8%L cingulumUnidentified100, 148, 910.014
3%L fasciculus uncinatus1%Frontal lobe112, 167, 910.026
3%Inferior L fronto-occipital fasciculus3%Frontal lobe107, 172, 910.026
37%L anterior thalamic radiation5%Caudate111, 141, 910.022
5%L superior longitudinal fasciculus17%Frontal lobe137, 127, 910.038
5%L superior longitudinal fasciculus (temporal part)17%Frontal lobe137, 127, 910.038
11%Forceps major2%Parietal lobe114, 71, 910.086
3%L Cingulum (hippocampus)1%Parietal lobe115, 70, 910.048
11%L inferior longitudinal fasciculus53%Occipital lobe120, 68, 910.022
5%Forceps major29%Occipital lobe115, 54, 910.038
3%Inferior L fronto-occipital fasciculus1%Parietal lobe115, 54, 910.038
5%Inferior L fronto-occipital fasciculus53%Occipital lobe124, 46, 910.032
16%L superior longitudinal fasciculus2%Parietal lobe129, 84, 910.018
13%L superior longitudinal fasciculus (temporal part)2%Parietal lobe129, 84, 910.018
3%L superior longitudinal fasciculus6%Temporal lobe135, 83, 910.022
3%L inferior longitudinal fasciculus54%Occipital lobe125, 49, 910.032

JHU, Areas according to the JHU white matter atlas; MNI, Areas according to the MNI coordinates.

Discussion

We found a widespread pattern of WM microstructural abnormalities extending beyond the MRI visible lesion and putative epileptogenic area in patients with frontal lobe epilepsy secondary to MRI identified FCD. Both groups (left and right-sided MRI lesions) demonstrated bilateral and widespread FA changes; however, these were slightly more extensive in the group with left-sided FCD. Perhaps this could be related to the fact that the dominant hemisphere for language may be more vulnerable to damage. In one study (Eriksson et al., 2001) of 22 epilepsy patients with FCD (although only four had MRI evidence of isolated lesions), all patients had DTI abnormalities corresponding to the MRI lesion. Fifteen of these patients had areas of structural disorganization as shown by decreased anisotropy or increased diffusivity values outside the lesion visible on conventional MRI (Eriksson et al., 2001). Decrease of FA was also detected in the superior longitudinal fasciculus in both analyses. This is the largest fiber tract of the long association fiber system and connects the prefrontal, parietal, and temporal cortices (Catani et al., 2002). We also found FA reduction in the uncinate fasciculus, which connects the anterior temporal lobe with medial and orbital prefrontal cortex areas in a bidirectional way (Schmahmann and Pandya, 2006). Reduced FA may indicate one of the three processes (or a combination of these): degradation of both axonal membranes and myelin (Beaulieu et al., 1996; Pierpaoli et al., 2001), abnormalities of myelin with sparing of the axons (Gulani et al., 2001; Song et al., 2002), or reduced density of myelinated axons (Takahashi et al., 2002). Unfortunately, we were not able to perform correlations between EEG abnormalities and FA abnormalities, or between the extent of visible FCD and the degree of FA abnormalities, because this was a group analysis. Another limitation of this paper is that we had confirmation of FCD on histopathology in only four patients, since the others are still waiting or refused surgery. Diffusion tensor imaging and tractography in patients with FCD may be useful in the detection and delineation of MRI-invisible structural abnormalities, and in determining both the connectivity of a given area of the cortex and the spatial relationship between the lesion and major white matter tracts. Further studies need to be conducted to evaluate the usefulness of DTI for the delineation of white matter abnormalities in patients with epilepsy.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  20 in total

1.  Magnetic resonance microimaging of intraaxonal water diffusion in live excised lamprey spinal cord.

Authors:  Masaya Takahashi; David B Hackney; Guixin Zhang; Suzanne L Wehrli; Alex C Wright; William T O'Brien; Hidemasa Uematsu; Felix W Wehrli; Michael E Selzer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

Review 2.  Aberrant neural circuits in malformations of cortical development and focal epilepsy.

Authors:  M Duchowny; P Jayakar; B Levin
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

3.  Diffusion tensor MR imaging of the human brain.

Authors:  C Pierpaoli; P Jezzard; P J Basser; A Barnett; G Di Chiro
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

4.  Changes in water diffusion due to Wallerian degeneration in peripheral nerve.

Authors:  C Beaulieu; M D Does; R E Snyder; P S Allen
Journal:  Magn Reson Med       Date:  1996-10       Impact factor: 4.668

5.  Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water.

Authors:  Sheng-Kwei Song; Shu-Wei Sun; Michael J Ramsbottom; Chen Chang; John Russell; Anne H Cross
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

6.  Classification system for malformations of cortical development: update 2001.

Authors:  A J Barkovich; R I Kuzniecky; G D Jackson; R Guerrini; W B Dobyns
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

7.  Apparent diffusion tensor measurements in myelin-deficient rat spinal cords.

Authors:  V Gulani; A G Webb; I D Duncan; P C Lauterbur
Journal:  Magn Reson Med       Date:  2001-02       Impact factor: 4.668

8.  Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome.

Authors:  L Tassi; N Colombo; R Garbelli; S Francione; G Lo Russo; R Mai; F Cardinale; M Cossu; A Ferrario; C Galli; M Bramerio; A Citterio; R Spreafico
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

9.  Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results.

Authors:  A Palmini; A Gambardella; F Andermann; F Dubeau; J C da Costa; A Olivier; D Tampieri; P Gloor; F Quesney; E Andermann
Journal:  Ann Neurol       Date:  1995-04       Impact factor: 10.422

10.  Diffusion tensor imaging in patients with epilepsy and malformations of cortical development.

Authors:  S H Eriksson; F J Rugg-Gunn; M R Symms; G J Barker; J S Duncan
Journal:  Brain       Date:  2001-03       Impact factor: 13.501

View more
  9 in total

1.  Bilateral white matter abnormality in children with frontal lobe epilepsy.

Authors:  Elysa Widjaja; Antonella Kis; Cristina Go; O Carter Snead; Mary Lou Smith
Journal:  Epilepsy Res       Date:  2013-12-12       Impact factor: 3.045

Review 2.  Pre-operative evaluation in pediatric patients with cortical dysplasia.

Authors:  Elia M Pestana Knight; Jorge Gonzalez-Martinez; Ajay Gupta
Journal:  Childs Nerv Syst       Date:  2015-08-18       Impact factor: 1.475

3.  Widespread cortical dyslamination in epilepsy patients with malformations of cortical development.

Authors:  David Tanne; Yaniv Assaf; Eyal Lotan; Omri Tomer; Ido Tavor; Ilan Blatt; Hadassah Goldberg-Stern; Chen Hoffmann; Galia Tsarfaty
Journal:  Neuroradiology       Date:  2020-09-25       Impact factor: 2.804

4.  Whole-brain MRI phenotyping in dysplasia-related frontal lobe epilepsy.

Authors:  Seok-Jun Hong; Boris C Bernhardt; Dewi S Schrader; Neda Bernasconi; Andrea Bernasconi
Journal:  Neurology       Date:  2016-01-13       Impact factor: 9.910

Review 5.  Functional network alterations and their structural substrate in drug-resistant epilepsy.

Authors:  Lorenzo Caciagli; Boris C Bernhardt; Seok-Jun Hong; Andrea Bernasconi; Neda Bernasconi
Journal:  Front Neurosci       Date:  2014-12-11       Impact factor: 4.677

6.  Sulcus-based MR analysis of focal cortical dysplasia located in the central region.

Authors:  Pauline Roca; Charles Mellerio; Francine Chassoux; Denis Rivière; Arnaud Cachia; Sylvain Charron; Stéphanie Lion; Jean-François Mangin; Bertrand Devaux; Jean-François Meder; Catherine Oppenheim
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

7.  Abnormal Profiles of Local Functional Connectivity Proximal to Focal Cortical Dysplasias.

Authors:  René M H Besseling; Jacobus F A Jansen; Anton J A de Louw; Mariëlle C G Vlooswijk; M Christianne Hoeberigs; Albert P Aldenkamp; Walter H Backes; Paul A M Hofman
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

8.  Reduced structural connectivity between sensorimotor and language areas in rolandic epilepsy.

Authors:  René M H Besseling; Jacobus F A Jansen; Geke M Overvliet; Sylvie J M van der Kruijs; Saskia C M Ebus; Anton de Louw; Paul A M Hofman; Johannes S H Vles; Albert P Aldenkamp; Walter H Backes
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

9.  Personalized microstructural evaluation using a Mahalanobis-distance based outlier detection strategy on epilepsy patients' DTI data - Theory, simulations and example cases.

Authors:  Gyula Gyebnár; Zoltán Klimaj; László Entz; Dániel Fabó; Gábor Rudas; Péter Barsi; Lajos R Kozák
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.